We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Universal Logistics Holdings
ULH
$393M
| $1.7M | ﹤0.01% |
53,600
-7,300
| -12% | -$241K |
|
1252
Coherus Oncology
CHRS
$221M
| $1.7M | ﹤0.01% |
176,600
+75,200
| +74% | +$761K |
|
1253
Beazer Homes USA
BZH
$906M
| $1.69M | ﹤0.01% |
175,140
+3,600
| +2% | +$49.4K |
|
1254
Stewart Information Services
STC
$2.13B
| $1.69M | ﹤0.01% |
38,800
+20,400
| +111% | +$1.04M |
|
|
DCH
1255
Dauch Corp
DCH
$1.32B
| $1.69M | ﹤0.01% |
247,350
-36,100
| -13% | -$325K |
|
|
CCF
1256
DELISTED
Chase Corporation
CCF
| $1.68M | ﹤0.01% |
20,100
-200
| -1% | -$17.7K |
|
1257
Brinker International
EAT
$8.73B
| $1.68M | ﹤0.01% |
67,200
+48,300
| +256% | +$1.3M |
|
|
NVTA
1258
DELISTED
Invitae Corporation
NVTA
| $1.67M | ﹤0.01% |
680,389
-3,171,875
| -82% | -$9.63M |
|
1259
Kelly Services Class A
KELYA
$568M
| $1.67M | ﹤0.01% |
123,000
+3,800
| +3% | +$68.6K |
|
1260
Origin Bancorp
OBK
$1.7B
| $1.67M | ﹤0.01% |
43,300
-1,600
| -4% | -$66.4K |
|
1261
Gladstone Investment Corp
GAIN
$651M
| $1.67M | ﹤0.01% |
137,642
-34,300
| -20% | -$493K |
|
|
KALV
1262
DELISTED
KalVista Pharmaceuticals
KALV
| $1.66M | ﹤0.01% |
114,622
-9,000
| -7% | -$126K |
|
1263
Illinois Tool Works
ITW
$85.4B
| $1.66M | ﹤0.01% |
9,200
-2,100
| -19% | -$414K |
|
1264
Virgin Galactic
SPCE
$314M
| $1.66M | ﹤0.01% |
17,625
-24,750
| -58% | -$3.18M |
|
1265
Brixmor Property Group
BRX
$9.82B
| $1.66M | ﹤0.01% |
89,600
-19,600
| -18% | -$423K |
|
|
MAGN
1266
Magnera Corp
MAGN
$489M
| $1.65M | ﹤0.01% |
40,877
+39,846
| +3,865% | +$2.77M |
|
1267
Anika Therapeutics
ANIK
$218M
| $1.65M | ﹤0.01% |
69,283
-15,600
| -18% | -$359K |
|
1268
Granite Construction
GVA
$5.17B
| $1.65M | ﹤0.01% |
64,900
+50,300
| +345% | +$1.48M |
|
1269
Ennis
EBF
$556M
| $1.65M | ﹤0.01% |
81,800
+2,200
| +3% | +$46.4K |
|
1270
Skywest
SKYW
$4.46B
| $1.65M | ﹤0.01% |
101,300
+33,700
| +50% | +$714K |
|
|
ITOS
1271
DELISTED
iTeos Therapeutics
ITOS
| $1.64M | ﹤0.01% |
86,200
-69,000
| -44% | -$1.59M |
|
1272
PTC
PTC
$14.9B
| $1.64M | ﹤0.01% |
+15,700
| New | +$1.79M |
|
|
ZEN
1273
DELISTED
ZENDESK INC
ZEN
| $1.64M | ﹤0.01% |
21,500
-174,200
| -89% | -$13.2M |
|
1274
NVR
NVR
$17.4B
| $1.64M | ﹤0.01% |
410
| – | – |
|
1275
Mitek Systems
MITK
$756M
| $1.63M | ﹤0.01% |
177,600
+23,800
| +15% | +$239K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.